The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The interleukin 6 pathway and atherosclerosis
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, individuals with a common IL-6 receptor (IL-6R) variant, D358A, which limits IL-6 action, displayed both reduced CRP and CVD events26,27.”
From Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis (2023) · cites this paper as [27]
Citations
Cites
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Research works printed but not linked: 3
- Boekholdt, 2012, The interleukin-6 pathway and atherosclerosis, Lancet, 379, 1176, 10.1016/S0140-6736(12)60361-4 · DOI
- Jones, 2011, Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling, J Clin Invest, 121, 3375, 10.1172/JCI57158 · DOI
- Schuett, 2012, Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice, Arterioscler Thromb Vasc Biol, 32, 281, 10.1161/ATVBAHA.111.229435 · DOI
Cited by
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Self-citationIL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Self-citationTargeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Self-citationThe role of IL-6 in host defence against infections: immunobiology and clinical implications
Rose-John, S., Winthrop, K., & Calabrese, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.83 · Cited by 424
Self-citationInterleukin-6: from basic biology to selective blockade of pro-inflammatory activities
Scheller, J., Garbers, C., & Rose-John, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.002 · Cited by 308
Self-citation
Metadata
- Authors
- Scheller, J., & Rose-John, S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 380
- Issue
- 9839
- Pages
- 338
- ISSN
- 0140-6736
- Cited by
- 56
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The interleukin 6 pathway and atherosclerosis. https://app.cochat.ai/papers/10.1016/s0140-6736(12)61246-x
- The paper
- Scheller, J., & Rose-John, S. (2012). The interleukin 6 pathway and atherosclerosis. The Lancet. https://doi.org/10.1016/s0140-6736(12)61246-x
